Why do psychiatric drug research in children?

Lancet

Volumn 361, Issue 9364, 2003, Pages 1147-1148

  Wiznitzer, Max ^a   Findling, Robert L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLUOXETINE; NORADRENALIN; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; COGNITION; DEPRESSION; DRUG INDUSTRY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; GENETIC PREDISPOSITION; HUMAN; HYDROCORTISONE RELEASE; MENTAL DISEASE; NOTE; OBSESSIVE COMPULSIVE DISORDER; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY;

EID: 0037420523     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12967-4     Document Type: Note

References (13)

1. US Food and Drug Administration. FDA approves Prozac for pediatric use to treat depression and OCD. FDA Talk Paper, T03-01, Jan 3, 2003: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01187.html (accessed March 20, 2003).
2. Hyman S.E. Mood disorders in children and adolescents: an NIMH perspective. Biol Psychiatry. 49:2001;962-969.
3. Carrey N. Developmental neurobiology: implications for pediatric psychopharmacology. Can J Psychiatry. 46:2001;810-818.
4. Hazell P., O'Connell D., Heathcote H., Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2:2002;CD002317.
5. Kessler R.C., Avenevoli S., Merikangas K.R. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 49:2001;1002-1014.
6. Piacentini J., Bergman R.L. Obsessive-compulsive disorder in children. Psychiatr Clin North Am. 23:2000;519-533.
7. Kaufman J., Martin A., King R.A., Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biol Psychiatry. 49:2001;980-1001.
8. Vitiello B. Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics. 108:2001;983-989.
9. Weintrob N., Cohen D., Klipper-Aurbach Y., Zadik Z., Dickerman Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med. 156:2002;696-701.
10. Zito J.M., Safer D.J., dosReis S., et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 157:2003;17-25.
11. Michael K.D., Crowley S.L. How effective are treatments for child and adolescent depression? A meta-analytic review. Clin Psychol Rev. 22:2002;247-269.
12. March Js, Franklin M., Nelson A., Foa E. Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol. 30:2001;8-18.
13. A 14 month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 56:1999;1073-1086.